It often surprises just how many people get a head and neck cancer. I recently discovered a singer/song writer favourite, John Prine, had a cancer back in the 90s and Val Kilmer recently confirmed that he actually did have a cancer this year (after first denying it.) Both survived and are apparently going strong - something the stories below suggest are becoming more of the norm. However, as always, a little skepticism never hurts.
The best example of the difference between cats and dogs is that after a three day business trip, my dogs are happy I'm back and my cats are mad that I was gone.
Or maybe uneducated people without money are "poor" while educated people without money are "broke."
Head and neck cancer cured with THIS treatment: Swollen glands were only symptoms
(U.K.) Sylvia White, 58, was hit with the devastating news she had a tumour behind her nose in 2014.
The mum-of-one, from Southampton, underwent months of gruelling chemotherapy and image-guided radiotherapy which appeared to stop the cancer - the size of a large marble - in its tracks.
Sylvia and her husband Neil, a Professor in Electronics and Computer Science at the University of Southampton, were hit with the devastating blow that the cancer had returned in August last year.
Sylvia is now cancer free after deciding to undergo Proton Beam Therapy away from the NHS in Prague, at the same clinic that treated UK toddler Ashya King back in 2014.
Neil said: “Sylvia had a few problems with her nose and her hearing, and she had some swollen glands on her neck. But for the most part her symptoms were fairly minor and not that obvious.
Immunotherapy kinder than chemotherapy for patients with head and neck cancer (U.K.)
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer - easing many of the negative effects of the disease on patients' quality of life.
Both head and neck cancer and the treatment for it can have a huge impact on patients - affecting their speech, breathing, eating and drinking, facial appearance, and general wellbeing.
All of this can cause substantial psychological, as well as physical, distress.
But patients taking part in a major phase III clinical trial reported that nivolumab helped them maintain a better quality of life for longer.
By contrast, the study—led by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust—found that people treated with standard chemotherapies docetaxel, methotrexate or cetuximab reported a decline in quality of life from the start of treatment.
Last year, the clinical trial of 361 patients found that nivolumab—which sparks the immune system into action against cancers—greatly increased survival for people with recurrent or metastatic head and neck cancer.
But the drug was initially rejected by NICE in April this year and is currently under consultation before a final decision is due.
The new results add to the growing body of evidence that immunotherapy can be a smarter, kinder treatment for people with cancer.
Full Story: :